Industry
Partnership Expands to Advance Novel Dual-Detection of Two Neglected Tropical Diseases
PATH, a non-profit leader in global health equity, Signal Diagnostics, a company of Alere Inc., and the [US] National Institute of Allergy and Infectious Diseases will collaborate on a rapid point-of-care combined test for both onchocerciasis and lymphatic filariasis, often co-endemic diseases. More...08 Mar 2015
Healthcare Revolution Predicted with Rise of Genomic Testing for Personalized Medicine
A new Frost & Sullivan analysis has found that the direct-to-individual sector of genomic testing is now thriving, though not without criticism about the potential medical interpretation of some forms of tests that may have been initially requested for nonmedical purposes, such as those for genealogy analysis. More...04 Mar 2015
Artel Expands Portfolio with STRATEC Partnership for Automation Technology
Artel, a leader in laboratory liquid handling measurement systems, and STRATEC Biomedical, a leader in automated systems for clinical diagnostics and biotechnology, have entered into a strategic partnership for STRATEC’s innovative “Tholos” technology, which measures liquid and solid contents of 96- and 384-well microplates. More...16 Feb 2015
After First Approval of a Rapid Molecular Test, Expect More
According to Kalorama Information, the first CLIA-waiver approval for broad use of a rapid molecular diagnostic test for influenza, from Alere, demonstrates the potential for the molecular point-of-care sector predicted in Kalorama’s 2014 report. More...15 Feb 2015
Collaboration Agreement Targets Tumor-Related Genes
A German biomedical company has entered into a collaborative agreement with a major Norwegian hospital that focuses on the identification of cancer-related tumor genes that predict a patient’s response or resistance to targeted therapies. More...02 Feb 2015
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Electrolyte Analyzer
BKE-B
New
HIV-1 Molecular Diagnostic Assay
AltoStar HIV RT-PCR Kit 1.5
In Other News
Emerging Products Provide Opportunity in Prenatal Diagnostics
Premarket Approval Sought for CDx Test to Benefit Lung Cancer Patients
Report Predicts Double-Digit Growth for Protein Microarrays
Aperiomics Presents Innovative Diagnostics Technology
WEF Selects Transasia Bio-Medicals for Global Growth Company Award
Testing On Tissues and Cells Sector Reaches USD 7.5 Billion
Bacterial Infection Assay Receives First Simultaneous FDA Clearance and CLIA Waiver
Strong Growth Forecasted for Women's Health Diagnostics
Merger Expected to Accelerate Development of Personalized Medicine Solutions
Diagnostics Rapidly Gain Ground in Infectious Diseases Sector
Robot-Assisted PCR Among Innovations Driving qPCR Sector
Roche Acquires High-Precision Dissection Technology from AvanSci Bio
Ferring and Roche Collaborate on Personalized Infertility Treatment
Roche Enters Additional Sectors with Acquisition of Ariosa
Physician Office Testing Found Responsive to Developing World Needs
Foundations Fund Fast-Track Development of Ebola Test
TESARO and Myriad Expand Collaboration with New CDx Pair
Women’s Health Diagnostics Grows to USD 8 Billion Sector
Oncology Companion Diagnostics Sector Grows to Over USD 1 Billion
Collaboration to Bring Personalized Cancer Care to Singapore
Market for qPCR Exceeds USD 3 Billion
Eurofins Genomics Buys VBC-Biotech Businesses, Establishes Austrian Subsidiary
Aperiomics Launches Novel NGS Services
LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.
